Transcriptomics

Dataset Information

0

RNA-seq performed on either wild-type, p53 null, or p21 null MMTV-Wnt1 mouse mammary tumors treated with or without doxorubicin.

ABSTRACT: The effects of doxorubicin on mammary tumors

ORGANISM(S): Mus musculus

PROVIDER: GSE133683 | GEO | 2019/07/03

REPOSITORIES: GEO

Json Xml

Similar Datasets

Genomics RNA-seq performed on either wild-type, p53 null, or p21 null MMTV-Wnt1 mouse mammary tumors treated with or without doxorubicin.
| PRJNA552227 | ENA
Unknown Mechanism of inhibition of MMTV-neu and MMTV-wnt1 induced mammary oncogenesis by RARalpha agonist AM580.
| S-EPMC2891995 | biostudies-literature
Unknown Chromatin effector Pygo2 regulates mammary tumor initiation and heterogeneity in MMTV-Wnt1 mice.
| S-EPMC3913260 | biostudies-literature
Transcriptomics Transcription profiling of Brca1- and p53-deficient mouse mammary tumors to treatment with doxorubicin, docetaxel or cisplatin
2007-06-18 | E-NCMF-5 | biostudies-arrayexpress
Unknown Loss of Limb-Bud-and-Heart (LBH) attenuates mammary hyperplasia and tumor development in MMTV-Wnt1 transgenic mice.
| S-EPMC6368957 | biostudies-literature
Transcriptomics mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells
2016-06-09 | GSE77841 | GEO
Unknown FAK activates AKT-mTOR signaling to promote the growth and progression of MMTV-Wnt1-driven basal-like mammary tumors.
| S-EPMC7268629 | biostudies-literature
Genomics Detoxifying doxorubicin
| PRJNA422761 | ENA
Unknown Dietary suppression of the mammary CD29(hi)CD24(+) epithelial subpopulation and its cytokine/chemokine transcriptional signatures modifies mammary tumor risk in MMTV-Wnt1 transgenic mice.
| S-EPMC4034693 | biostudies-literature
Transcriptomics Identification of p53-regulated genes in wild-type p53 or p53-null HCT116 cells
2019-01-29 | GSE125787 | GEO